← Back to Search

TeaM OUT Intervention for Lung Nodules(TeaMOUT Trial)

Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston, SC
Targeting 3 different conditionsTeaM OUT Intervention +1 moreN/AWaitlist AvailableLed by Christopher G. Slatore, MD MSResearch Sponsored by VA Office of Research and Development

TeaMOUT Trial Summary

This trial will evaluate the effectiveness of a smoking cessation outreach intervention on increasing use of smoking cessation resources in Veterans.

Eligible Conditions
  • Tobacco Use
  • Solitary Pulmonary Nodule
  • Pulmonary Nodules

TeaMOUT Trial Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below
Select...
You are currently smoking cigarettes.

TeaMOUT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~56 weeks after exposure to team out intervention or enhanced usual care
This trial's timeline: 3 weeks for screening, Varies for treatment, and 56 weeks after exposure to team out intervention or enhanced usual care for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
7-day point prevalence nicotine abstinence
Smoke
Secondary outcome measures
Incremental Behavior Change Toward Smoking Cessation (IBC-S)
Utilization of cessation resources
Other outcome measures
Interventional procedure

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

TeaMOUT Trial Design

2Treatment groups
Experimental Treatment
Group I: TeaM OUT InterventionExperimental Treatment1 Intervention
The TeaM OUT Intervention has 2 elements: 1) a letter that a) describes the nodule and the importance of cessation related to the pulmonary nodule (i.e. teachable moment) and b) notification that a Proactive IVR Quit line will initiate contact and 2) call(s) from the Proactive IVR Quit Line which a) offers smoking cessation resources and b) helps connect the patient to those resources.
Group II: Enhanced Usual CareExperimental Treatment1 Intervention
The Enhanced Usual Care arm also has two elements: 1) a letter that a) describes the nodule without linking it to smoking cessation (i.e. no teachable moment) with b) wording to contact an Optional IVR Quit line if desired and 2) the Optional IVR Quit line which a) offers smoking cessation resources and b) helps connect the patient to those resources.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Enhanced Usual Care
2010
Completed Phase 3
~7780

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,583 Previous Clinical Trials
2,895,275 Total Patients Enrolled
4 Trials studying Tobacco Use
2,634 Patients Enrolled for Tobacco Use
Minneapolis Veterans Affairs Medical CenterFED
69 Previous Clinical Trials
12,269 Total Patients Enrolled
Ralph H. Johnson VA Medical CenterFED
18 Previous Clinical Trials
3,188 Total Patients Enrolled

Media Library

Enhanced Usual Care Clinical Trial Eligibility Overview. Trial Name: NCT04574518 — N/A
Tobacco Use Research Study Groups: TeaM OUT Intervention, Enhanced Usual Care
Tobacco Use Clinical Trial 2023: Enhanced Usual Care Highlights & Side Effects. Trial Name: NCT04574518 — N/A
Enhanced Usual Care 2023 Treatment Timeline for Medical Study. Trial Name: NCT04574518 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any open slots in this experiment for participants?

"Clinicaltrials.gov displays that this medical research is not currently seeking participants, despite having been posted on August 12th 2022 and last edited a week later. Nevertheless, at present there are 76 other trials searching for prospective candidates."

Answered by AI
~686 spots leftby May 2024